Meningococcal Antigen Typing System Development and Application to the Evaluation of Effectiveness of Meningococcal B Vaccine and Possible Use for Other Purposes

Development of the 4-component meningococcal serogroup B vaccine (4CMenB) has required new assays for the reliable evaluation of the expression and cross-reactivity of those specific antigen variants that are predicted to be targeted by bactericidal antibodies elicited by the vaccine in different is...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Immunol Res
Autors principals: Domnich, Alexander, Gasparini, Roberto, Amicizia, Daniela, Boccadifuoco, Giuseppe, Giuliani, Marzia Monica, Panatto, Donatella
Format: Artigo
Idioma:Inglês
Publicat: Hindawi Publishing Corporation 2015
Matèries:
Review Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4553328/
https://ncbi.nlm.nih.gov/pubmed/26351645
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/353461
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars